Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Aetna isn't a single entity
The phase 3 SURMOUNT programme assessed the safety and efficacy of tirzepatide as obesity treatment and the medication has now been approved (November 2023) for chronic weight management by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) [46, 47]
High fat diets are out, high fat diets are in
Novo Nordisk has also committed an additional $10 billion investment towards manufacturing in the U.S., including a commitment to produce the Wegovy pill end-to-end in the U.S
Check whether the source is human, animal, in-vitro or supplier documentation
US$ 27.34
US$ 23.34
US$ 26.03
US$ 21.05
